Based on results from other studies, showing that CB2, but not CB1, activation is involved in attenuation of bladder inflammation and the severity of experimental cystitis [37,38], we speculated that CB2 and PPARγ are the most probable targets of CBD in SV-HUC1 cells. The gene discussed is PPARG; the disease is chronic cystitis.